CAY10499

CAY10499 is an inhibitor of Lipases and FAAH used in studies of Metabolic Signaling. In practice, this places the compound in experiments that measure metabolic regulation, energy sensing, and enzyme-linked homeostasis in inflammation, metabolism, and neuroscience models.

By inhibiting Lipases and FAAH, CAY10499 can be used to examine metabolic regulation, energy sensing, and enzyme-linked homeostasis. The enzyme annotation adds relevance to enzyme-activity assays, substrate-conversion studies, and mechanism profiling, together with downstream-response mapping in the same experimental setting. In inflammation, metabolism, and neuroscience models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.

Research Applications

• Target-focused assays involving Lipases and FAAH
• Pathway perturbation studies connected to Metabolic Signaling
• Concentration-response inhibition and target-dependence studies
• Enzyme-activity assays, substrate-conversion studies, and mechanism profiling

Overall, CAY10499 is appropriate when a defined chemical perturbant is needed to connect Lipases and FAAH with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in inflammation, metabolism, and neuroscience models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.